Ziconotide (Zic)

Ziconotide is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus, a cone snail, it is the synthetic form of an ω-conotoxin peptide. Ziconotide is derived from the toxin of the cone snail species Conus magus. Scientists have been intrigued by the effects of the thousands of chemicals in marine snail toxins since the initial investigations in the late 1960s by Baldomero Olivera. Olivera, now a professor of biology in the University of Utah, was inspired by accounts of the deadly effects of these toxins from his childhood in the Philippines. Ziconotide was discovered in the early 1980s by University of Utah research scientist Michael McIntosh, when he was barely out of high school and working with Baldomero Olivera. Ziconotide was developed into an artificially manufactured drug by Elan Corporation.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins CPX168Ge11 BSA Conjugated Ziconotide (Zic) Immunogen; SDS-PAGE; WB.
Antibodies MAX168Ge21 Monoclonal Antibody to Ziconotide (Zic) WB; IHC; ICC; IP.
MAX168Ge22 Monoclonal Antibody to Ziconotide (Zic) WB; IHC; ICC; IP.
MAX168Ge23 Monoclonal Antibody to Ziconotide (Zic) WB; IHC; ICC; IP.
Assay Kits CEX168Ge ELISA Kit for Ziconotide (Zic) Enzyme-linked immunosorbent assay for Antigen Detection.